81 results on '"Vizoso F"'
Search Results
2. Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis
3. P005 Correlation of tissue expression of matrix metalloproteinases and their inhibitors with recurrence and progression in non-muscle invasive bladder cancer
4. Matrix Metalloproteinases and Bladder Cancer: What is New?
5. Duodenal Expression of Toll-Like Receptors and Interleukins Are Increased in Both Children and Adult Celiac Patients
6. 691 Function of the Pit-1 transcription factor in breast cancer
7. 696 Regulation of MMP-13 (collagenase-3) by the transcription factor Pit-1
8. 284 EXPRESSION OF MATRIX METALLOPROTEASES AND THEIR INHIBITORS BY STROMAL CELLS IN PROSTATE CARCINOMA COMPARED TO THEIR EXPRESSION IN NON MALIGNANT CONDITIONS OF THE PROSTATE (PIN, BPH)
9. 672 EXPRESSION OF METALLOPROTEASES (MMPS) AND THEIR INHIBITORS (TIMPS) IN TUMOUR AND STROMAL CELLS AS MARKERS OF RECURRENCE AFTER RADICAL PROSTATECTOMY. UNIVARIATE AND MULTIVARIATE STUDY COMBINED WITH CLUSTER ANALYSIS OF THE PROTEIN EXPRESSION IN PROSTATE CANCER TISSUE ARRAY SAMPLES
10. The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors
11. Study of matrix metalloproteinases and their inhibitors in prostate cancer
12. Expression of metalloproteases and their inhibitors in different histological types of breast cancer
13. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas
14. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: Relationship with clinicopathological characteristics, biological features and prognosis
15. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast
16. Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse
17. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast
18. Study of matrix metalloproteinases and their inhibitors in breast cancer
19. Significance of Collagenase 3 (Matrix Metalloproteinase 13) in Invasive Bladder Cancer: Correlation with Pathological Parameters
20. Expression and prognostic value of EGFR in invasive breast cancer
21. Cytosolic levels of TFF1/pS2 in breast cancer: their relationship with clinical–pathological parameters and their prognostic significance
22. Collagenase-3 (MMP-13) Expression in Cutaneous Malignant Melanoma
23. Clinical Significance of Cathepsin D Concentration in Tumor Cytosol of Primary Breast Cancer
24. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer
25. Epidermal Growth Factor Receptor and c-erbB-2 Contents in Unresectable (UICC R1 or R2) Gastric Cancer
26. Epidemiología de la enfermedad inflamatoria intestinal crónica en cinco áreas de Asturias: España
27. Clinical Significance of the Epidermal Growth Factor Receptor and HER2 Receptor in Resectable Gastric Cancer
28. Características, patrón de manejo y pronóstico del cáncer colorrectal
29. Significación clínica del contenido tumoral del receptor del factor de crecimiento epidérmico en el cáncer de mama
30. Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer
31. Incidencia y prevalencia en enfermedad inflamatoria intestinal crónica: Estudio asturiano en cinco áreas (EIICEA). España
32. Prognostic Significance of Tissue-Type Plasminogen Activator (tPA) Content in Gastric Cancer and Surrounding Mucosa
33. Importancia de la edad como factor pronóstico determinante de la variabilidad de las características clínico-patológicas de las pacientes con cáncer de mama
34. Clinical Significance of Pepsinogen C Tumor Expression in Patients with Stage D2 Prostate Carcinoma
35. Expresión y significación clínica del pepsinógeno C y la colagenasa-3 en el carcinoma de endometrio
36. Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma
37. Análisis del contenido citosólico de la proteína pS2 en el cáncer de mama
38. Niveles séricos preoperatorios del CEA y pronóstico en el cáncer colorrectal
39. Epidemiología de la enfermedad inflamatoria intestinal crónica en Gijón. Asturias
40. Pepsinogen C: A Possible Biological Marker of Epithelial Differentiation in Barrett's Esophagus
41. Prognostic Significance of Cytosolic pS2 Protein Content in Gastric Cancer
42. Clinical Significance of Epidermal Growth Factor Receptor Content in Gastric Cancer
43. Estrogen and Progesterone Receptors in Colorectal Cancer and Surrounding Mucosa
44. Expression and Clinical Significance of Pepsinogen C in Resectable Pancreatic Cancer
45. Hyaluronic acid as prognostic marker in resectable colorectal cancer
46. Expression and Prognostic Significance of Pepsinogen C in Gastric Carcinoma
47. Relationship of Tumoral Hyaluronic Acid and Cathepsin D Contents with Histological Type of Gastric Carcinoma
48. c-erbB-2 Oncoprotein Content in Gastric Cancer and in Adjacent Mucosa
49. CD44s, CD44v5 and CD44v6 Protein Contents in Colorectal Cancer and Surrounding Mucosa
50. Pepsinogen C Expression in Tumors of Extragastric Origin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.